This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Northwestern University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shuo Yang - Innovator in Cancer Treatment
Introduction
Shuo Yang is an accomplished inventor based in Lisle, IL (US). He is currently affiliated with Northwestern University, where he focuses on developing innovative solutions for cancer treatment. Despite having no granted patents to date, his research contributions are significant and impactful.
Latest Patent Applications
Shuo Yang has been involved in several notable patent applications. One of his latest applications is for "Targeted pH Sensitive Liposomes." This application discloses synthetic nanoparticles, pharmaceutical compositions, kits, or methods for treating and/or preventing cancer. The synthetic nanoparticles and/or pharmaceutical compositions comprise a pH sensitive liposome, an apolipoprotein, and andrographolide or a derivative thereof. These nanoparticles are designed to be delivered to a subject for the treatment of cancer, specifically targeting T-cell lymphoma or B-cell lymphoma.
Another significant application is for "Nanostructures for Treating Cancers and Other Conditions." This application provides nanostructures, compositions, and methods for treating cancers and other conditions. The nanostructures and/or compositions may be used to treat cancers or other diseases by controlling cholesterol metabolism in cells. They may also be utilized to kill cancer cells, including those affected by scavenger receptor type B-I (SR-B1), B-cell lymphoma cells, non-Hodgkin's lymphoma cells, and melanoma cells. In some embodiments, these nanostructures may mimic natural high-density lipoprotein (HDL).
Conclusion
Shuo Yang is a dedicated inventor whose work at Northwestern University is paving the way for innovative cancer treatments. His latest patent applications reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
